000099190 001__ 99190
000099190 005__ 20210902121938.0
000099190 0247_ $$2doi$$a10.31083/J.EJGO.2020.06.2185
000099190 0248_ $$2sideral$$a122688
000099190 037__ $$aART-2020-122688
000099190 041__ $$aeng
000099190 100__ $$aNavarro Sierra, J.
000099190 245__ $$aPrimary endometrial carcinoma with signet-ring cells. A case report and review of the literature
000099190 260__ $$c2020
000099190 5060_ $$aAccess copy available to the general public$$fUnrestricted
000099190 5203_ $$aEndometrial adenocarcinoma with signet-ring cells is an infrequent histological type of carcinoma that usually corresponds to a metastasis of a primary carcinoma of another origin, mainly from the gastrointestinal tract or the breast. For this reason, in view of this histological finding, it is essential to carry out a thorough evaluation including mammography, gastroscopy, colonoscopy and thoracoabdominopelvic CT. To date, only six cases of primary endometrial carcinoma with signet-ring cells have been reported in the English literature. A 73-year-old patient was referred to the Gynecology Department with a 3-day history of postmenopausal bleeding. She was diagnosed with primary endometrial adenocarcinoma with signet-ring cells. The anatomopathological special features of the surgical specimen are presented, as well as the evolution of the patient, who remained asymptomatic and free of disease 28 months after surgery. A review of the literature is performed, emphasizing the peculiarities of this rare histological subtype. Despite the fact that primary endometrial carcinoma with signet-ring cells is an infrequent tumor, it must be considered in the differential diagnosis of malignant tumors of aforesaid origin. It is essential to carry out a correct and an extensive investigative study as well as an immunohistochemical analysis of the samples obtained for its confirmation diagnosis.
000099190 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttp://creativecommons.org/licenses/by/3.0/es/
000099190 590__ $$a0.196$$b2020
000099190 591__ $$aONCOLOGY$$b240 / 242 = 0.992$$c2020$$dQ4$$eT3
000099190 591__ $$aOBSTETRICS & GYNECOLOGY$$b81 / 83 = 0.976$$c2020$$dQ4$$eT3
000099190 592__ $$a0.15$$b2020
000099190 593__ $$aOncology$$c2020$$dQ4
000099190 593__ $$aObstetrics and Gynecology$$c2020$$dQ4
000099190 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000099190 700__ $$aEspiau Romera, A.
000099190 700__ $$aNarváez Salazar, M.
000099190 700__ $$0(orcid)0000-0001-9109-5487$$aPuente Luján, M.J.
000099190 700__ $$aEizaguirre Zarza, B.
000099190 700__ $$aBaquedano Mainar, L.
000099190 773__ $$g41, 6 (2020), 879-883$$pEur. j. gynaecol. oncol.$$tEUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY$$x0392-2936
000099190 8564_ $$s409031$$uhttps://zaguan.unizar.es/record/99190/files/texto_completo.pdf$$yVersión publicada
000099190 8564_ $$s2858755$$uhttps://zaguan.unizar.es/record/99190/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000099190 909CO $$ooai:zaguan.unizar.es:99190$$particulos$$pdriver
000099190 951__ $$a2021-09-02-10:59:33
000099190 980__ $$aARTICLE